Mesothelioma Trials: Suberoylanilide Hydroxamic Acid (SAHA)

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

The pharmaceutical company Merck is recruiting participants for a clinical trial of Suberoylanilide Hydroxamic Acid (SAHA) to treat mesothelioma. The study is designed to evaluate the effectiveness of this treatment when compared to study participants given a placebo.

The study is being conducted at healthcare facilities in Illinois, Maryland, Michigan, Pennsylvania and Texas. In addition, researchers are participating in this trial in the following countries: Australia, Belgium, Brazil, Germany, Italy, the Netherlands, New Zealand, Spain, Sweden and the United Kingdom. For more information about this study in the U.S., contact Merck at their toll-free information line at 1-(800) 577-8839.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.

If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.